Animal Testing And Non-Animal Alternative Testing Global Market Opportunities And Strategies To 2035
March 2020
291
About the Report
About the Report
This report describes and evaluates the animal testing and non-alternative testing market in major geographies.
Animal testing or experiment on animals done in the early stages of drug development and for toxicity and safety assessment of medical devices, chemicals, pesticides, cosmetics, and food compounds. Animal experiments are necessary before testing on humans mainly to evaluate toxicity, pharmacokinetics, and safety of a drug or a chemical. However, there is an increasing pressure from the animal welfare organizations on governmental agencies and companies to use non-animal alternative testing technologies. These technologies include in-vitro cell and tissue cultures, organ-on-chip, computer simulations, 3D bio printing of tissues, and synthetic skin substitutes, among others. Industries such as pharmaceuticals, medical devices, chemicals & pesticides and food are increasingly adopting these technologies to replace animal testing.
Animal Testing
The global animal testing market was valued at USD 10.74 billion in 2019and the market is expected to grow at a compound annual growth rate (CAGR) of 4.27% during 2019-2025 and at a CAGR of 2.46% during 2025-2035. USA and Japan are the major animal testing markets in the world.The USA's animal testing market was valued at USD 4.67 billion in 2019, and is expected to grow at a CAGR of 1.49% during 2019-2025 and at a CAGR of 0.57% during 2025-2035.Japan's animal testing market was valued at USD 1.03 billion in 2019. The market is forecast to grow at a CAGR of 3.51% during 2019-2025, and at a CAGR of 1.73% during 2025-2035.
The growth of the animal testing market in the USA and Japan is mainly due to the rise in R&D activities in end-use industries, and regulations to conduct animal experiments before testing on humans. However, the slow anticipated future growth rates (from 2018 to 2035) can be attributed to the requirement from federal agencies on biopharma companies to adopt 3R principles (i.e. to replace, reduce, and refine animals used in the laboratory research), protests from animal welfare organizations. In 2019, the US Environmental Protection Agency (EPA) decided to rule out mammal testing for chemicals by 2035, and increasing preference by end-use industries towards the adoption of non-animal testing technologies.
Non-Animal Testing
The global non-animal alternative testing market was valued at USD 1.11 billion in 2019. The market is expected to grow at a CAGR of 10.40% during 2019-2025. The USA's non-animal alternative testing technology market was valued at USD 0.336 billion in 2019. The USA's market is forecast to grow at a CAGR of 11.99% through 2025. Japan's non-animal alternative testing technology market was valued at USD 0.058 billion in 2019 and the market is forecast to grow at a CAGR of 6.79% through 2025.
The growth in the non-animal alternative testing market is mainly due to the adoption of the 3R principles by both regulatory agencies, and end-use companies, especially in the cosmetic industry. The adoption of alternative technologies is expected to grow after 2025 post regulatory agencies' validation and approval.
The non-animal alternative testing market trends in the USA and Japan include raising investment for the development of alternatives to animal testing technologies, increasing adoption of in-vitro and in-silico technologies by the pharmaceutical industry, and the use of non-animal testing methods in the cosmetics industry.
The major drivers of the non-animal alternative testing technologies market include technological advances in drug development, ethical concerns on animal experimentations, high costs of animal studies, government programs for non-animal testing, and increasing social awareness against animal cruelty. Factors that could hinder the growth of the non-animal testing include regulatory mandate on animal testing for drug/medical device approval, limitations in in-vitro testing technologies, and a lack of predictive ability of in-vitro testing over in-vivo testing.
The non-animal alternative testing market is fragmented with major developers contributing to around 15-20% of the total market in 2018. Some of the major developers of alternative testing technologies in the USA include Emulate Inc, Organovo Holdings, MatTek Corporation & EMD Millipore. The major Japanese developers include J-TEC, Reprocell Inc. and Organ Technologies.
Comparative Analysis And Regulatory Landscape
Animal tests including genetic toxicity, eye irritation, skin corrosion, skin sensitivity, and others are costlier when compared to non-animal testing technologies. High costs of animal testing include the cost of the animal, and the animal testing operation costs such as maintenance of animals and cost for human resource personnel. Considering all these, the costs for animal testing methods are higher than non-animal alternative testing methods.
In the USA, there are several regulatory agencies including the US Public Health Service, USDA, IACUS, AAALAC, and EPA that are responsible for animal research and welfare. Regulatory agencies for cosmetics have not mandated animal testing in the USA. However, all other industries including pharmaceuticals, medical devices, chemicals, and pesticides require animal testing for new drugs/chemicals before regulatory approval. In Japan, several regulatory agencies including the ministry of environment, MHLW, MEXT, and MAFF are responsible for conducting animal experiments. Companies in Japan are also trying to follow 3R principles from a legal, ethical and scientific point of view.
Alternative Testing Technologies In End Use Industries
Companies in the USA and Japan are developing alternative testing technologies such as cell and tissue culture (in-vitro), organ-on-chip, and in-silico technologies. Cosmetics and bio-pharma industries use these technologies to evaluate toxicity, efficacy, pharmacokinetics, and safety of a drug or a chemical. These technologies vary by the accuracy in drug screening and selection, efficacy, cost and time of the test results. Alternative technologies are widely adopted by cosmetic companies to understand eye irritation, skin irritation and safety studies of chemicals.
The cosmetics segment occupies the major market share in the alternative testing market followed by the medical devices and pharma industries. This is mainly due to the preference of choosing non-animal technologies by cosmetic companies due to several reasons such as potential cost savings, changing attitudes of consumers, and regulatory changes.
There is a need for validated non-animal alternatives for pharma and other end-use industries; hence, the non-animal alternative testing technology developers should focus on getting OECD approval for their developed technologies. The adoption rate of non-animal alternative testing technologies will be high in developed countries compared to emerging nations; hence, non-animal alternative testing technology developers should focus initially on developed markets. These developers should collaborate with animal welfare organizations for better promotion of their products.
Products
Products
By Type Of End Use Industrial Application: Pharmaceuticals; Academic Research; Medical Devices; Chemicals & Pesticides; Cosmetics; Others
Companies
Emulate, Inc.; Organovo Holdings, Inc.; MatTek Corporation; EMD Millipore; China Tissue Engineering Co., Ltd. (J-TEC); ReproCell Inc; Organ Technologies Co, Ltd; Episkin
Table of Contents
Table of Contents
1. Animal Testing And Non-Animal Alternative Testing Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction
6.1.1. Segmentation By Geography
6.1.2. Segmentation By End User Industry
7. Animal Testing And Non-Animal Alternative Testing Market Characteristics
7.1.1. Animal Testing
7.1.2. Non-Animal Alternative Testing
7.1.3. Facts About Animals In Research-Functional Resemblances Of Animals To Human Body
8. Animal Testing And Non-Animal Alternative Testing Market, Value Chain Analysis
8.1.1. Animal Breeders and Suppliers
8.1.2. Non-Animal Alternative Testing Technology Developers
8.1.3. Regulatory Authorities
8.1.4. Alternative Testing Service Providers
8.1.5. End-Use Industries
9. Non-Animal Alternative Testing Trends
9.1. Increasing Collaborations & Partnerships To Reduce Animal Testing
9.2. Raising Investments And Research Grants For Developing Alternative Technologies
9.3. Non-Animal Testing Methods In The Cosmetics Industry Are Gaining Traction
10. Cost Analysis For Animal Testing And Alternative Technologies
10.1.1. Average Cost Of Laboratory Animals
10.1.2. Average Cost Of Non-Animal Alternative Testing Methods
10.1.3. Comparative Cost Analysis For Animal Testing And Alternative Methods
10.2. Costs Involved In Animal Testing, 2018
11. Animal Testing And Non-Animal Alternative Testing Market Segments
11.1. By End Use Industrial Application
11.1.1. Important Areas of Use
11.1.2. End-User Applications
11.2. Animal Testing Market By Animal Type
11.2.1. Mice
11.2.2. Rat
11.2.3. Frogs
11.2.4. Fish
11.2.5. Birds
11.2.6. Guinea pig
11.2.7. Hamster
11.2.8. Rabbits
11.2.9. Sheep
11.2.10. Dogs
11.2.11. Cats
11.2.12. Monkeys
11.2.13. Pigs
11.2.14. Others
12. Number Of Animals Used In Research, By Country
12.1.1. USA
12.1.2. Europe
12.1.3. United Kingdom (UK)
12.1.4. Germany
12.1.5. France
12.1.6. Australia
12.1.7. Canada
12.1.8. China
13. Non-Animal Alternative Testing Technologies By Type And End Use
13.1. Introduction
13.2. Types Of Non-Animal Alternative Testing Technologies
13.2.1. Cell Or Tissue Culture (In-Vitro)
13.2.2. Organ-On-Chip (OOC)
13.2.3. Global OOC Market Size And Growth
13.2.4. Global OOC Market Drivers And Restraints
13.2.5. Market Drivers
13.2.6. Market Restraints
13.2.7. In-silico (Computer-Based Models)
13.2.8. Artificial Skin Models (Skin Substitutes)
13.2.9. Other Technologies
14. End-User Industries Adoption To Alternative Testing Technologies
14.1. Adoption of Alternative Testing Technologies By Type of Industry
14.1.1. Cosmetics Industry
14.1.2. Pharmaceutical Industry
14.1.3. Medical Device Industry
14.1.4. Others
14.2. Adoption of 3R's In USA
14.2.1. 3R Adoption In The Cosmetics Industry
14.2.2. 3R Adoption In The Pharmaceutical Industry
14.2.3. 3R Adoption In The Medical Device Industry
14.3. Adoption of 3R's In China
14.3.1. 3R Adoption In The Cosmetics Industry
14.3.2. 3R Adoption In The Pharmaceutical Industry
14.3.3. 3R Adoption In The Medical Device Industry
14.4. Adoption of 3R's In Europe
14.4.1. 3R Adoption In The Cosmetics Industry
14.4.2. 3R Adoption In The Pharmaceutical Industry
14.4.3. 3R Adoption In The Medical Device Industry
15. Global Animal Testing And Non-Animal Testing Market
15.1. Global Animal Testing Market Size And Growth
15.1.1. Global Animal Testing Market Value (USD Billion)
15.1.2. Global Animal Testing Market, By Volume (Million Units)
15.1.3. Drivers Of The Animal Testing Market
15.1.4. Restraints On The Animal Testing Market
15.2. Global Non-Animal Alternative Testing Market Size And Growth
15.2.1. Global Non-Animal Alternative Testing Market Value (USD Billion)
15.2.2. Drivers Of The Non-Animal Alternative Testing Market
15.2.3. Restraints On The Non-Animal Alternative Testing Market
16. Animal Testing And Non-Animal Testing Market, Regional And Country Analysis
17. USA Animal Testing And Non-Animal Alternative Testing Market
17.1. USA Animal Testing Market
17.1.1. USA Animal Testing Market Value (USD Billion)
17.1.2. USA Animal Testing Market, By Volume (Million Units)
17.2. USA Non-Animal Alternative Testing Market
17.2.1. USA Non-Animal Alternative Testing Market Value (USD Billion)
17.3. USA Animal Testing Market By End Use Industrial Application
17.3.1. Market By Value And Volume
17.3.2. Pharmaceuticals
17.3.3. Academic Research industry was the second largest
17.3.4. Medical Devices industry was the third largest
17.3.5. Chemicals And Pesticides industry was the fourth largest
17.3.6. Cosmetics industry was the smallest
17.3.7. Other industries were the fifth largest
17.3.8. Share Of Top 5 Companies, By Revenue (In Each Industrial Application)
17.4. Regulatory Landscape In The USA
17.4.1. Regulatory Bodies & Policies
17.4.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market
18. Japan Animal Testing And Non-Animal Alternative Testing Market
18.1. Japan Animal Testing Market
18.1.1. Japan Animal Testing Market Value (USD Billion)
18.1.2. Japan Animal Testing Market, By Volume (Million Units)
18.2. Japan Non-Animal Alternative Testing Market
18.2.1. Japan Non-Animal Alternative Testing Market Value (USD Billion)
18.3. Japan Animal Testing Market By End Use Industrial Application
18.3.1. Share Of Top 5 Companies, By Revenue (In Each Industrial Application)
18.4. Regulatory Landscape In Japan
18.4.1. Regulatory Bodies & Policies
18.4.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market
19. China Animal Testing And Non-Animal Alternative Testing Market
19.1. China Animal Testing Market
19.1.1. China Animal Testing Market Value (USD Billion)
19.1.2. China Animal Testing Market, By Volume (Million Units)
19.2. Regulatory Landscape In China
19.2.1. Regulatory Bodies & Policies
19.2.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market
20. Australia Animal Testing And Non-Animal Alternative Testing Market
20.1. Australia Animal Testing Market
20.1.1. Australia Animal Testing Market Value (USD Billion)
20.1.2. Australia Animal Testing Market, By Volume (Million Units)
20.2. Regulatory Landscape In Australia
20.2.1. Regulatory Bodies & Policies
20.2.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market
21. Europe Animal Testing And Non-Animal Alternative Testing Market
21.1. Regulatory Landscape In Europe
21.1.1. EU Directive 2010/63
21.2. Europe Non-Animal Alternative Testing Market
21.2.1. Europe Non-Animal Alternative Testing Market Value (USD Billion)
22. France Animal Testing And Non-Animal Alternative Testing Market
22.1. France Animal Testing Market
22.1.1. France Animal Testing Market Value (USD Billion)
22.1.2. France Animal Testing Market, By Volume (Million Units)
22.2. France Animal Testing Market By End Use Industrial Application
22.2.1. Market By Value And Volume
22.2.2. Pharmaceuticals
22.2.3. Academic Research industry was the second largest
22.2.4. Chemicals & Pesticides industry was the third largest
22.2.5. Medical Devices industry was the fourth largest
22.2.6. Cosmetics industry was the smallest
22.2.7. Other industries were the fifth largest
22.3. Regulatory Landscape In France
22.3.1. Regulatory Bodies & Policies
22.3.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market
23. Germany Animal Testing And Non-Animal Alternative Testing Market
23.1. Germany Animal Testing Market
23.1.1. Germany Animal Testing Market Value (USD Billion)
23.1.2. Germany Animal Testing Market, By Volume (Million Units)
23.2. Germany Animal Testing Market By End Use Industrial Application
23.2.1. Market By Value And Volume
23.2.2. Pharmaceuticals
23.2.3. Academic Research industry was the second largest
23.2.4. Medical Devices industry was the third largest
23.2.5. Chemicals And Pesticides industry was the fifth largest
23.2.6. Cosmetics industry was the smallest
23.2.7. Other industries were the fifth largest
23.3. Regulatory Landscape In Germany
23.3.1. Regulatory Bodies & Policies
23.3.2. Proposed Regulations & Guidelines Driving the Animal Testing Alternatives Market
24. UK Animal Testing And Non-Animal Alternative Testing Market
24.1. UK Animal Testing Market
24.1.1. UK Animal Testing Market Value (USD Billion)
24.1.2. UK Animal Testing Market, By Volume (Million Units)
24.2. UK Animal Testing Market By End Use Industrial Application
24.2.1. Market By Value And Volume
24.2.2. Pharmaceuticals
24.2.3. Academic Research industry was the second largest
24.2.4. Medical Devices industry was the third largest
24.2.5. Chemicals & Pesticides industry was the fifth largest
24.2.6. Cosmetics industry was the smallest
24.2.7. Other industries were the fourth largest
24.3. Regulatory Landscape in United Kingdom (UK)
24.3.1. Regulatory Bodies & Policies
24.3.2. Proposed Regulations & Guidelines Driving the Animal Testing Alternatives Market
25. Canada Animal Testing And Non-Animal Alternative Testing Market
25.1. Canada Animal Testing Market
25.1.1. Canada Animal Testing Market Value (USD Billion)
25.1.2. Canada Animal Testing Market, By Volume (Million Units)
25.2. Regulatory Landscape In Canada
25.2.1. Regulatory Bodies & Policies
25.2.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market
26. Rest Of The World Animal Testing And Non-Animal Alternative Testing Market
26.1. Rest Of The World Animal Testing Market
26.1.1. Rest Of The World Animal Testing Market Value (USD Billion)
26.1.2. Rest Of The World Animal Testing Market, By Volume (Million Units)
26.2. Rest of The World Non-Animal Alternative Testing Market
26.2.1. Rest of The World Non-Animal Alternative Testing Market Value (USD Billion)
26.3. Regulatory Landscape In Rest of the World (RoW)
26.3.1. Regulatory Bodies & Policies
26.3.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market
27. Competitive Landscape For Non-Animal Alternative Technologies
27.1. USA Non-Animal Alternative Testing Market Competitive Landscape
27.1.1. Emulate, Inc
27.1.2. Organovo Holdings, Inc
27.1.3. MatTek Corporation
27.1.4. EMD Millipore
27.2. China Non-Animal Alternative Testing Market Competitive Landscape
27.2.1. China Tissue Engineering Co., Ltd. (J-TEC)
27.2.2. ReproCell Inc
27.2.3. Organ Technologies Co, Ltd
27.3. Europe Non-Animal Alternative Testing Market Competitive Landscape
27.3.1. Episkin
28. Animal Testing And Non Animal Alternative Testing Global Market Opportunities And Strategies
28.1. Global Animal Testing Market In 2035 – Geographies Offering Most New Opportunities
28.2. Global Non-Animal Alternative Testing Market In 2035 – Geographies Offering Most New Opportunities
28.3. Global Animal Testing And Non-Animal Alternative Testing Market In 2035 – Segments Offering Most New Opportunities
28.4. Global Animal Testing And Non-Animal Alternative Testing Market In 2023 – Growth Strategies
28.4.1. Non-Animal Alternative Testing Market Trend Based Strategies
28.4.2. Competitor Strategies
29. Conclusions & Recommendations
29.1. Conclusions
29.2. Recommendations
29.2.1. Product
29.2.2. Price
29.2.3. Place
29.2.4. Promotion
29.2.5. People
29.2.6. Need For Validated Non-Animal Alternatives For Pharma And Other End-Use Industries
29.2.7. Increasing Number Of Players In The Non-Animal Alternative Testing Market
29.2.8. Focus On Developed Countries
29.2.9. Collaborations With Technology Developers And Animal Welfare Organizations For Promotion
30. Appendix
30.1. Glossary
30.2. Market Data Sources
30.3. Research Methodology
30.3.1. OCED Accepted In Vito Tests
30.4. Survey on Animal Models & Testing Landscape in the US
30.4.1. Current Condition By Company
30.4.2. Number Of Animals Used In Testing
30.5. Expert Interviews List
30.6. Non Animal Alternative Testing Interviews
30.7. USA Interviews
30.7.1. Interview 1
30.7.2. Interview 2
30.7.3. Interview 3
30.7.4. Interview 4
30.7.5. Interview 5
30.7.6. Interview 6
30.7.7. Interview 7
30.7.8. Interview 8
30.7.9. Interview 9
30.8. China Interviews
30.8.1. Interview 10
30.8.2. Interview 11
30.8.3. Interview 12
30.8.4. Interview 13
30.8.5. Interview 14
30.8.6. Interview 15
30.9. Animal Testing Interviews
30.9.1. Interview 16
30.9.2. Interview 17
30.9.3. Interview 18
30.9.4. Interview 19
30.9.5. Interview 20
30.9.6. Interview 21
30.9.7. Interview 22
31. Interview 23
List of Figure
Figure 1: Global Animal Testing And Non-Animal Alternative Testing Market Size And Growth Comparison
Figure 2: Global Growth Of Non-Animal Alternative Testing Market By Country
Figure 3: Global Animal Testing Market Segmentation By End User Industry
Figure 4: Value Chain Analysis For Animal Testing & Non-Animal Alternative Testing Market
Figure 5: Statistics of Scientific Procedures on Living Animals in the UK, 2018
Figure 6: Animal Used by Species Group, 2018, (%) (i) Re-use (II) Excludes Re-use
Figure 7: Global OOC Market, Historic Market Size, 2015-2019, USD Million
Figure 8: Global OOC Market, Forecast Market Size, 2019-2023, USD Million
Figure 9: Animal Testing & Non-Animal Alternative Testing Share In The Major End-Use Industries
Figure 10: Global Animal Testing Market Size, 2019-2035, USD Billion
Figure 11: Global Animal Testing Market, Volume, 2019-2035, Million Units
Figure 12: Global Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion
Figure 13: USA Animal Testing Market Size, 2019-2035, USD Billion
Figure 14: USA Animal Testing Market, Volume, 2019-2035, Million Units
Figure 15: USA Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion
Figure 16: USA Animal Testing Market, By End Use Industrial Application, By Value (USD Billion), And By Volume (Millions) 2019
Figure 17: Japan Animal Testing Market Size, 2019-2035, USD Billion
Figure 18: Japan Animal Testing Market, Volume, 2019-2035, Million Units
Figure 19: Japan Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion
Figure 20: China Animal Testing Market Size, 2019-2035, USD Billion
Figure 21: China Animal Testing Market, Volume, 2019-2035, Million Units
Figure 22: Australia Animal Testing Market Size, 2019-2035, USD Billion
Figure 23: Australia Animal Testing Market, Volume, 2019-2035, Million Units
Figure 24: Europe Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion
Figure 25: France Animal Testing Market Size, 2019-2035, USD Billion
Figure 26: France Animal Testing Market, Volume, 2019-2035, Million Units
Figure 27: France Animal Testing Market, By End Use Industrial Application, By Value, 2019, USD Billion
Figure 28: Germany Animal Testing Market Size, 2019-2035, USD Billion
Figure 29: Germany Animal Testing Market, Volume, 2019-2035, Million Units
Figure 30: Germany Animal Testing Market, By End Use Industrial Application, By Value, 2019, USD Billion
Figure 31: UK Animal Testing Market Size, 2019-2035, USD Billion
Figure 32: UK Animal Testing Market, Volume, 2019-2035, Million Units
Figure 33: UK Animal Testing Market, By End Use Industrial Application, By Value, 2019, USD Billion
Figure 34: Canada Animal Testing Market Size, 2019-2035, USD Billion
Figure 35: Canada Animal Testing Market, Volume, 2019-2035, Million Units
Figure 36: Rest Of The World Animal Testing Market Size, 2019-2035, USD Billion
Figure 37: Rest Of The World Animal Testing Market, Volume, 2019-2035, Million Units
Figure 38: Rest of The World Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion
List of Table
Table 1: Average Cost Of Animals, 2018 (USD )
Table 2: Estimated Cost Analysis For Animal Testing And Non-Animal Alternative Testing Methods, 2018 (USD )
Table 3: Number of Animals Used in Research in the US, 2017
Table 4: Number of Animals Used in Research, UK, 2018
Table 5: Number of Animals Used in Research, Germany, 2018
Table 6: Animal Used by species Group, Germany, (% Share), 2018
Table 7: Number of Animals Used in Research, France, 2017
Table 8: Cell Culture As An Alternative to Animal Testing, Major Cell Culture Developers Worldwide
Table 9: Global OOC Market, Historic Market Size, 2015-2019, USD Million
Table 10: Global OOC Market, Historic Market Size, 2015-2019, USD Million
Table 11: Organ-On-Chips As An Alternative To Animal Testing, Major OOC Developers Worldwide
Table 12: Computer Simulation As An Alternative to Animal Testing, Major In-Silico Model Developers
Table 13: Artificial Skin Model As An Alternative To Animal Testing, Major Artificial Skin Model Developers
Table 14: Non-Animal Alternative Testing Methods Accepted By The US Agencies
Table 15: Non-Animal Alternative Testing Methods Accepted By The China Agencies
Table 16: Non-Animal Alternative Testing Methods Accepted By The European Commission
Table 17: Global Animal Testing Market Size, 2019-2035, USD Billion
Table 18: Global Animal Testing Market, Volume, 2019- 2035, Million Units
Table 19: Global Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion
Table 20: USA Animal Testing Market Size, 2019-2035, USD Billion
Table 21: USA Animal Testing Market, Volume, 2019- 2035, Million Units
Table 22: USA Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion
Table 23: USA Animal Testing Market, By End Use Industrial Application, By Value (USD Billion), And By Volume (Millions) 2019,
Table 24: USA Animal Testing Market, Share of Top 5 Companies (In Each Industrial Application), 2018
Table 25: Laboratory Animal Testing Regulatory Landscape In The USA
Table 26: Japan Animal Testing Market Size, 2019-2035, USD Billion
Table 27: Japan Animal Testing Market, Volume, 2019- 2035, Million Units
Table 28: Japan Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion
Table 29: Japan Animal Testing Market, Share of Top 5 Companies (In Each Industrial Application), 2018
Table 30: Laboratory Animal Testing Regulatory Landscape In Japan
Table 31: China Animal Testing Market Size, 2019-2035, USD Billion
Table 32: China Animal Testing Market, Volume, 2019- 2035, Million Units
Table 33: Laboratory Animal Testing Regulatory Landscape In China
Table 34: Australia Animal Testing Market Size, 2019-2035, USD Billion
Table 35: Australia Animal Testing Market, Volume, 2019- 2035, Million Units
Table 36: Laboratory Animal Testing Regulatory Landscape In Australia
Table 37: Europe Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion
Table 38: France Animal Testing Market Size, 2019-2035, USD Billion
Table 39: France Animal Testing Market, Volume, 2019- 2035, Million Units
Table 40: France Animal Testing Market, By End Use Industrial Application, By Value, 2019, USD Billion
Table 41: Laboratory Animal Testing Regulatory Landscape In France
Table 42: Germany Animal Testing Market Size, 2019-2035, USD Billion
Table 43: Germany Animal Testing Market, Volume, 2019- 2035, Million Units
Table 44: Germany Animal Testing Market, By End Use Industrial Application, By Value, 2019, USD Billion
Table 45: Laboratory Animal Testing Regulatory Landscape In Germany
Table 46: UK Animal Testing Market Size, 2019-2035, USD Billion
Table 47: UK Animal Testing Market, Volume, 2019- 2035, Million Units
Table 48: UK Animal Testing Market, By End Use Industrial Application, By Value, 2019, USD Billion
Table 49: Laboratory Animal Testing Regulatory Landscape In The UK
Table 50: Canada Animal Testing Market Size, 2019-2035, USD Billion
Table 51: Canada Animal Testing Market, Volume, 2019- 2035, Million Units
Table 52: Laboratory Animal Testing Regulatory Landscape In Canada
Table 53: Rest Of The World Animal Testing Market Size, 2019-2035, USD Billion
Table 54: Rest Of The World Animal Testing Market, Volume, 2019- 2035, Million Units
Table 55: Rest Of The World Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion
Table 56: Laboratory Animal Testing Regulatory Landscape In RoW
Table 57: Emulate Inc, Product Portfolio
Table 58: Emulate Inc, Product & Services
Table 59: Organovo, Product Portfolio
Table 60: MatTek, Product Portfolio
Table 61: EMD Millipore, Product Portfolio
Table 62: J-TEC, Product Portfolio
Table 63: ReproCell, Product Portfolio
Table 64: Organ Technologies Product Portfolio
Table 65: Episkin, Product Portfolio
Table 66: Global Animal Testing Market Size Gain (USD Billion), 2019-2023, By Country
Table 67: Global Non-Animal Alternative Market Size Gain (USD Billion), 2019-2023, By Country
Table 68: Global Animal Testing And Non-Animal Alternative Testing Market Size Gain (USD Billion), Segmentation By Type, 2019-2035
Table 69: Market Data Sources
Table 70: OECD Accepted In-Vitro Tests For Medical Devices
Table 71: Number Of Animals Tested Globally in 2018
Table 72: Expert Interviews List
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.